Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
This report contains market size and forecasts of Cardiac Resynchronization Therapy Devices in global, including the following market information:
Global Cardiac Resynchronization Therapy Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiac Resynchronization Therapy Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiac Resynchronization Therapy Devices companies in 2021 (%)
The global Cardiac Resynchronization Therapy Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pacemaker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Resynchronization Therapy Devices include Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, MicroPort, Medico, Lepu (Qinming Medical), IMZ and Cardioelectronica and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Resynchronization Therapy Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Resynchronization Therapy Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy Devices Market Segment Percentages, by Type, 2021 (%)
Pacemaker
ICD
CRT
Global Cardiac Resynchronization Therapy Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy Devices Market Segment Percentages, by Application, 2021 (%)
Bradycardia
Tachycardia
Heart Failure
Others
Global Cardiac Resynchronization Therapy Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Resynchronization Therapy Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiac Resynchronization Therapy Devices revenues share in global market, 2021 (%)
Key companies Cardiac Resynchronization Therapy Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiac Resynchronization Therapy Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
St. Jude Medical (Abbott)
Boston Scientific
Biotronik
MicroPort
Medico
Lepu (Qinming Medical)
IMZ
Cardioelectronica
Pacetronix